Lin Elizabeth Yeuinsider trades
In SEC Form 4 filings, Lin Elizabeth Yeu is listed as Chief Medical Officer of Tarsus Pharmaceuticals, Inc. (TARS). In the last 90 days, Lin Elizabeth Yeu sold $2.12M of Tarsus Pharmaceuticals, Inc. (TARS) on the open market and bought none. All 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TARSTarsus Pharmaceuticals, Inc. | Chief Medical Officer | 7 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TARSTarsus Pharmaceuticals, Inc. | Sep 4 | Sep 9 | S | 5,387 | $85.00 | Sale −$457,895 | 7,933 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 4 | Sep 9 | S | 5,386 | $90.00 | Sale −$484,740 | 2,547 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 4 | Sep 9 | S | 1,590 | $85.00 | Sale −$135,150 | 3,180 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 4 | Sep 9 | S | 1,590 | $90.00 | Sale −$143,100 | 1,590 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 2 | Sep 3 | S | 5,387 | $80.00 | Sale −$430,960 | 13,320 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 2 | Sep 3 | S | 1,590 | $80.00 | Sale −$127,200 | 4,770 | Yes | Form 4 |
| TARSTarsus Pharmaceuticals, Inc. | Sep 1 | Sep 3 | S | 4,601 | $73.86 | Sale −$339,830 | 18,707 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.